Phase II Trial of Avelumab in Combination with Gemcitabine in Advanced Leiomyosarcoma As a Second-Line Treatment (KCSG UN18-06)
ANNALS OF ONCOLOGY（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined